Imeglimin - CAS# 775351-65-0 Catalog No.:M10356-2 Quizartinib (AC220) is a novel

Quizartinib (AC220) is a novel compound expressly optimized as a FLT3 inhibitor for the treatment of acute myeloid leukemia (AML)

Smiles: CN1C(=O)N(CCCCN2CCN(CC2)C2N=CC=CN=2)N=CC1=O

Molecular Weight: 554

InChiKey: XREWXJVMYAXCJV-UHFFFAOYSA-N

PMID: 26435360

Imeglimin - CAS# 775351-65-0 Catalog No.:M10356-2 Quizartinib (AC220) is a novelImeglimin is an oxidative phosphorylation blocker that acts to inhibit hepatic gluconeogenesis, increase muscle glucose uptake, and restore normal insulin secretion. Imeglimin is being developed as an oral anti diabetic. Various research protocols are being known through various scientists. Early studies showed that imeglimin is as effective as metformin in regulating glycaemic control. (last updated : 2 19 2016). Product information CAS Number: